03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Doliprane Suppositories 1g* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Sanofi |
Responsible Party | Aventis Pharma Spécialités |
Origin | France |
Manufacturer | Aventis Pharma Specialites |
Origin | France |
ATC | N02BE01 |
Doliprane Suppositories 1g* :
Doliprane Suppositories 1g* :
Doliprane Suppositories 1g* :
Doliprane Suppositories 1g* :
Doliprane Suppositories 1g* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Doliprane Suppositories 1g* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Agranulocytosis | Not known |
Anal irritation | Not known |
Anaphylactic shock | Rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Rare |
Bronchospasm | Not known |
Cytolytic hepatitis | Not known |
Erythema | Rare |
Fixed pigmented erythema | Not known |
Haemolytic anemia | Not known |
Hepatitis acute | Not known |
Hypersensitivity reactions | Rare |
Kounis syndrome | Not known |
Leucopenia (Leukopenia) | Very rare |
Neutropenia | Very rare |
Serum transaminase increased | Not known |
Skin rash | Rare |
Thrombocytopenia (Thrombopenia) | Very rare |
Urticaria | Rare |
Doliprane Suppositories 1g* :
NB : Products With Same Indication |
Different Units By MoH Code
Doliprane Suppositories 1g* MoH 1744 :
Form | Suppository |
Package Size | Box of 8 |
Strength | 1g |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 148232/03 |
Submission date | 01/01/2003 |
Registration Year | 2003 |
Archived Date | 2017 |
Price Comparison
● Country: | France | |
● Package Size: | 8 | |
● Public Price: | 2.48 EUR | ( 240,252.48 LBP ) |
● Pack size unit used: | 8 | |
● Cost/Unit: | 0,31 EUR | ( 0.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File